Screener
Mirum Pharmaceuticals, Inc. MIRM Research and development expense
Research and development expense at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product sales, net | $176,243 | $127,785 | $336,125 | $239,370 |
| Operating expenses: | ||||
| Cost of sales | 30,348 | 23,421 | 59,153 | 46,439 |
| Research and development | 90,528 | 46,067 | 188,438 | 87,111 |
| Acquired in-process research and development | 16,435 | — | 742,737 | 5,000 |
| Selling, general and administrative | 81,469 | 63,286 | 177,799 | 120,992 |
| Total operating expenses | 218,780 | 132,774 | 1,168,127 | 259,542 |
| Loss from operations | (42,537) | (4,989) | (832,002) | (20,172) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s research and development expense?
- Mirum Pharmaceuticals, Inc. (MIRM) reported research and development expense of $90.53M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s research and development expense changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s research and development expense increased by 96.5% year-over-year, from $46.07M to $90.53M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s research and development expense?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s research and development expense has grown at a 8.4% compound annual growth rate (CAGR), from $131.43M to $181.18M.
- What does research and development expense mean?
- Research and development expense
Ask your AI about Mirum Pharmaceuticals, Inc.'s research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude